Reaction

Calculus Urinary reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,517 reports · 40 co-occurring drugs

As of the last recalculation, Calculus Urinary appears in 1,517 FAERS reports alongside 40 co-occurring drug terms. The strongest observed disproportionality signal is ATAZANAVIR (PRR 73.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Atazanavir	73	73.2	73.5
Ritonavir	85	42.2	42.3
Abacavir Sulfate	29	41.6	41.7
Zonisamide	39	37.1	37.2
Ritonavir 100 Mg	36	33.8	33.9
Dolutegravir Sodium	16	24.6	24.6
Lamivudine	46	21.0	21.1
Theophylline Anhydrous	16	17.9	17.9
Mometasone	23	17.5	17.5
Efavirenz	14	17.4	17.4
Theophylline	14	16.9	16.9
Icosapent Ethyl	10	16.2	16.2
Dextrose	15	15.8	15.8
Dextrose Monohydrate	15	15.5	15.6
Lamivudine Oral	26	14.3	14.3
Diltiazem Hydrochloride Extended-Release Tablets	11	13.4	13.4
Ceftriaxone	30	12.8	12.8
Zidovudine	12	12.4	12.4
Ceftriaxone Sodium	33	12.0	12.1
Teduglutide	11	11.3	11.3
Lopinavir And Ritonavir	11	11.2	11.2
Zinc	19	10.7	10.7
Zinc Chloride	19	10.6	10.6
Atovaquone	6	10.3	10.3
Amikacin	12	9.7	9.7
Piperacillin Sodium,Tazobactam Sodium	18	9.4	9.4
Thiotepa	6	8.7	8.7
Piperacillin And Tazobactam	8	8.6	8.6
Nevirapine	5	7.6	7.6
Darunavir	8	7.3	7.3
Romosozumab-Aqqg	7	7.1	7.1
Pegaspargase	6	6.7	6.7
Pitavastatin Calcium	5	6.7	6.7
Emtricitabine And Tenofovir Disoproxil Fumarate	21	6.4	6.4
Encorafenib	4	5.6	5.6
Tenofovir Disoproxil Fumarate	13	5.4	5.4
Sofosbuvir	7	4.9	4.9
Azacitidine For	6	4.5	4.5
Apalutamide	3	3.5	3.5
Pirfenidone	7	2.4	2.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.